Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Phase 2 Unknown 10 enrolled The University of New South Wales Australian Government Department of Health and Ageing · collab Kirketon Road Centre, Sydney Hospital · collab St Vincent's Hospital, Sydney · collab

RandomizedSingle-groupDouble-blindTreatment

Summary

The study aims to evaluate the safety and efficacy of modafinil (200 mg/day) over 10 weeks plus a tailored cognitive behavioural therapy program in the treatment of cocaine dependence.

Timeline

Start: 2005-07
Primary completion: —
Completion: 2007-09

Publications

Shearer J, Shanahan M, Darke S, Rodgers C, van Beek I, McKetin R, Mattick RP. A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence. Drug Alcohol Rev. 2010 May;29(3):235-42. doi: 10.1111/j.1465-3362.2009.00148.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Modafinil	Small molecule	200 mg	—

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Summary

Timeline

Publications

Drugs

Indications